“…Copper(II) complexes have also demonstrated anti-inflammatory properties that can be exploited in the treatment of rheumatoid arthritis. Jackson et al explored a series of Cu(II) tripeptide complexes, in which Cu(II) was square planar and first demonstrated that the complexes have sufficiently low stability constants to allow for their release in vivo [11]. Then, using techniques including EPR, NMR, absorption spectroscopy and DFT calculations, the authors were able to develop reasonable models to describe the coordination modes for each complex.…”